Ahmedabad: Neuberg Diagnostics has launched an upgraded genomic facility of Neuberg Centre for Genomic Medicine (NCGM) in Ahmedabad. The facility was inaugurated by Indian cricket legend M.S Dhoni in the presence of Dr GSK Velu, Chairman, and Managing Director, Neuberg Diagnostics, Dr Sandip Shah, Executive Director, Neuberg Diagnostics.
The Centre has a 30,000 sqft standalone premises with testing devices and provides research-based genomic service, including comprehensive range of genetic testing solutions and dedicated genetic counseling services. NCGM is genomics testing providers with genomics labs located in Ahmedabad, Chennai and North Carolina (USA).
NCGM is equipped with research infrastructure, high end -throughput sequencers, fragment analysers, and high-end HPC clusters for population-scale bioinformatics analysis. The centre is committed to researching and innovating in various fields, including Inherited Genomics, Reproductive Genomics, Cytogenetics, and Transplant Immunogenomics.
MS Dhoni expressed his excitement about the upgraded NCGM facilities and said, “I am proud to be a part of such a remarkable initiative that is dedicated to improving the lives of people through genomic medicine. NCGM’s commitment to providing comprehensive and cutting-edge services is truly inspiring.”
Dr Sandip Shah, Executive Director, Neuberg Diagnostics said, “With its focus on delivering the best-in-class genetic services, NCGM is poised to make a significant impact in the field of genomic medicine. NCGM is India’s largest Exclusive Genomic Testing Facility with 30,000 Sqft infrastructure combined with a team of highly skilled professionals, make NCGM a one-stop solution for genomic testing and research.”
Dr GSK Velu, Chairman & Managing Director, Neuberg Diagnostics said, “We are thrilled to have had the esteemed MS Dhoni join us for the inauguration of our upgraded facilities. His support and encouragement mean a great deal to us and we are grateful for his recognition of the important work we are doing at NCGM. We are committed to continuously improving our services in the field of genomic medicine to benefit the Society.”
